In addition to reflecting the dose-dependent nature of the SWI/SNF ATPase in cancer, our data in the AC is consistent with work done in C. elegans early mesoblast development where complete loss of the swsn-4 ATPase using a catalytically dead mutant and lineage-specific knockout strategy results in loss of cell cycle arrest [36]. This evidence concerns the gene DNAH8 and cancer.